We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+24.59%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$59.9B
AUM Growth
+$12.2B
(+25%)
Cap. Flow
+$2B
Cap. Flow
% of AUM
3.34%
Top 10 Holdings %
Top 10 Hldgs %
21.63%
Holding
3,213
New
281
Increased
1,628
Reduced
1,147
Closed
147
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$134M |
| 2 |
Microsoft
MSFT
|
+$119M |
| 3 |
Apple
AAPL
|
+$87.6M |
| 4 |
AbbVie
ABBV
|
+$61.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$54.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$92.9M |
| 2 |
RTN
Raytheon Company
RTN
|
+$71.6M |
| 3 |
CY
Cypress Semiconductor
CY
|
+$23.6M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$12.9M |
| 5 |
Domino's
DPZ
|
+$12.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.43% |
| 2 | Healthcare | 14.28% |
| 3 | Financials | 13.11% |
| 4 | Consumer Discretionary | 10.94% |
| 5 | Communication Services | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FRTA
2526
DELISTED
Forterra, Inc
FRTA
| $332K | ﹤0.01% |
29,723
+2,564
| +9% | +$21.2K |
|
2527
Primis Financial Corp
FRST
$404M
| $330K | ﹤0.01% |
34,061
-3,990
| -10% | -$38.4K |
|
2528
Shinhan Financial Group
SHG
$35.6B
| $330K | ﹤0.01% |
+13,704
| New | +$336K |
|
2529
Merchants Bancorp
MBIN
$2.49B
| $328K | ﹤0.01% |
26,609
+1,635
| +7% | +$17.3K |
|
2530
SAP
SAP
$238B
| $327K | ﹤0.01% |
+2,338
| New | +$288K |
|
2531
Greenlight Captial
GLRE
$506M
| $326K | ﹤0.01% |
49,960
+4,579
| +10% | +$30K |
|
|
GNTY
2532
DELISTED
Guaranty Bancshares
GNTY
| $325K | ﹤0.01% |
13,809
-5,847
| -30% | -$132K |
|
|
GSKY
2533
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
| $325K | ﹤0.01% |
+66,414
| New | +$285K |
|
|
BCLI
2534
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $324K | ﹤0.01% |
+1,927
| New | +$208K |
|
2535
MetroCity Bankshares
MCBS
$1.03B
| $324K | ﹤0.01% |
22,595
+7,795
| +53% | +$88.4K |
|
2536
NetEase
NTES
$84.7B
| $322K | ﹤0.01% |
+3,755
| New | +$283K |
|
|
ISEE
2537
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $322K | ﹤0.01% |
+63,179
| New | +$263K |
|
2538
National Bankshares
NKSH
$268M
| $321K | ﹤0.01% |
11,240
-990
| -8% | -$28.8K |
|
2539
Paysign
PAYS
$705M
| $321K | ﹤0.01% |
33,098
+2,765
| +9% | +$20.4K |
|
2540
Vera Bradley
VRA
$98.7M
| $320K | ﹤0.01% |
72,075
-8,186
| -10% | -$40.7K |
|
|
SMMF
2541
DELISTED
Summit Financial Group, Inc.
SMMF
| $320K | ﹤0.01% |
19,418
-1,566
| -7% | -$25.7K |
|
|
LBC
2542
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $320K | ﹤0.01% |
31,994
+1,875
| +6% | +$18.1K |
|
|
PRTK
2543
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $319K | ﹤0.01% |
61,073
+12,039
| +25% | +$53.5K |
|
|
CTO
2544
CTO Realty Growth
CTO
$815M
| $318K | ﹤0.01% |
29,630
+2,490
| +9% | +$27.5K |
|
2545
AXT Inc
AXTI
$5.8B
| $317K | ﹤0.01% |
66,521
+5,260
| +9% | +$24.8K |
|
2546
TAL Education Group
TAL
$6.87B
| $317K | ﹤0.01% |
+4,630
| New | +$265K |
|
2547
XBiotech
XBIT
$69.2M
| $317K | ﹤0.01% |
23,098
+6,663
| +41% | +$93.6K |
|
|
TBNK
2548
DELISTED
Territorial Bancorp Inc.
TBNK
| $316K | ﹤0.01% |
13,286
-5,873
| -31% | -$145K |
|
2549
Covenant Logistics
CVLG
$872M
| $315K | ﹤0.01% |
43,654
-6,210
| -12% | -$31.7K |
|
|
FPRX
2550
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $314K | ﹤0.01% |
51,530
-7,875
| -13% | -$32.4K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2020 Portfolio in Review
As of Q2 2020, RhumbLine Advisers held 3,213 positions worth $59.9B, up 25% from $47.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers deployed $2B of net new capital in Q2 2020, opening 281 new positions and adding to 1,628 existing holdings. Its largest new stake was Otis Worldwide: 701,378 shares worth $39.9M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core S&P Mid-Cap ETF, an estimated $12.9M trimmed.
- RhumbLine Advisers's largest Q2 2020 buy was Otis Worldwide: 701,378 shares worth $39.9M.
- RhumbLine Advisers added most to Amazon in Q2 2020, an estimated $134M increase.
- RhumbLine Advisers's biggest Q2 2020 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $12.9M.
- RhumbLine Advisers fully exited Allergan plc in Q2 2020, selling an estimated $92.9M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $59.9B portfolio in Q2 2020.
- RhumbLine Advisers opened 281 new positions and closed 147 in Q2 2020.
- RhumbLine Advisers's portfolio value rose 25% quarter-over-quarter to $59.9B.
Based on RhumbLine Advisers's 13F filing for Q2 2020, filed 13 Aug 2020.